Skip to main content

Advertisement

Log in

Sleeve Gastrectomy Plus Side-to-Side Jejunoileal Anastomosis for the Treatment of Morbid Obesity and Metabolic Diseases: a Promising Operation

  • Technical Innovation
  • Published:
Obesity Surgery Aims and scope Submit manuscript

Abstract

Background

The continuing need for simple, safe, and effective procedures led us to design a new operation for treating morbid obesity.

Methods

Thirty-two patients underwent our novel procedure, sleeve gastrectomy plus side-to-side jejunoileal anastomosis (SG plus), and were followed for 6 to 24 months. A matched cohort of 32 patients underwent sleeve gastrectomy over the same period and was used as the control group. Weight loss, comorbidity outcomes, and the duodenum to cecum transit time after a gastrografin swallow, performed at postoperative day 4, were compared.

Results

There were no deaths and no major perioperative complications. Three patients developed long-term complications requiring surgical intervention (intestinal obstruction, nausea–vomiting, and hypoalbuminemia). In the SG plus group, a 77.8 % excess weight loss was achieved at 12 months postoperatively, which was significantly better (p < 0.01) than the 67 % observed in the control group. The comorbidity outcomes, particularly diabetes resolution, were also significantly superior in the SG plus patients. The duodenum to cecum transit time of 11 min in the SG plus group was significantly shorter (p < 0.01) than the 31 min observed in the control group.

Conclusions

Sleeve gastrectomy plus side-to-side jejunoileal anastomosis appears to be a simple, considerably safe, and effective procedure for treating obesity and its metabolic comorbidities.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Aggarwal S, Kini SU, Herron DM. Laparoscopic sleeve gastrectomy for morbid obesity: a review. Surg Obes Relat Dis. 2007;3:189–94.

    Article  PubMed  Google Scholar 

  2. Melissas J, Koukouraki S, Askoxylakis J, et al. Sleeve gastrectomy—a restrictive procedure? Obes Surg. 2007;17:57–62.

    Article  PubMed  Google Scholar 

  3. Murphy KG, Dhillo WS, Bloom SR. Gut peptides in the regulation of food intake and energy homeostasis. Endocr Rev. 2006;27:719–27.

    Article  PubMed  CAS  Google Scholar 

  4. Gallgher TK, Geoghegan JG, Baird AW, et al. Implications of altered gastrointestinal motility in obesity. Obes Surg. 2007;17:1399–407.

    Article  Google Scholar 

  5. Rubino F, Zizzari P, Tomasetto C, et al. The role of the small bowel in the regulation of circulatin ghrelin levels and food intake in the obese Zucker rat. Endocrinology. 2005;16:1745–51.

    Article  Google Scholar 

  6. Bose M, Olivan B, Teixeira J, et al. Do incretins play a role in the remission of type 2 diabetes after gastric bypass surgery: what are the evidence? Obes Surg. 2009;19:217–29.

    Article  PubMed  Google Scholar 

  7. Wren AM, Bloom SR. Gut hormones and appetite control. Gastroenterology. 2007;132:2116–30.

    Article  PubMed  CAS  Google Scholar 

  8. Strader AD, Torsten PV, Jandacek RJ, et al. Weight loss through ileal transposition is accompanied by increased ileal hormone secretion and synthesis in rats. Am J Physiol Endocrinol Metab. 2005;288:E447–53.

    Article  PubMed  CAS  Google Scholar 

  9. Santoro S, Malzoni CE, Velhote MCP, et al. Digestive adaptation with intestinal reserve: a neuroendocrine-based operation for morbid obesity. Obes Surg. 2006;16:1371–79.

    Article  PubMed  Google Scholar 

  10. De Paula AL, Macedo ALV, Rassi N, et al. Laparoscopic treatment for type 2 diabetes mellitus for patients with a body mass index less than 35. Surg Endosc. 2008;22:706–16.

    Article  Google Scholar 

  11. Boza C, Gagner M, Devaud N, et al. Laparoscopic sleeve gastrectomy with ileal transposition (SGIT): a new surgical procedure as effective as gastric bypass for weight control in a porcine model. Surg Endosc. 2008;22:1029–34.

    Article  PubMed  Google Scholar 

  12. De Paula AL, Macedo ALV, Prudente AS, et al. Laparoscopic sleeve gastrectomy with ileal interposition (“neuroendocrine brake”)—pilot study of a new operation. Surg Obes Relat Dis. 2006;2:464–7.

    Article  PubMed  Google Scholar 

  13. Braghetto I, Davanzo C, Korn O, et al. Scintigraphic evaluation of gastric emptying in obese patients submitted to sleeve gastrectomy compared to normal subjects. Obes Surg. 2009;19:1515–21.

    Article  PubMed  Google Scholar 

  14. Melissas J, Daskalakis M, Koukouraki S, et al. Sleeve gastrectomy—a “food limiting” operation. Obes Surg. 2008;18:1251–56.

    Article  PubMed  Google Scholar 

  15. le Roux CW, Aylwin SJB, Batterham RL, et al. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss and improve metabolic parameters. Ann Surg. 2006;243:108–14.

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

All authors declare to have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to John Melissas.

Additional information

John Melissas and Anastasia Peppe contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Melissas, J., Peppe, A., Askoxilakis, J. et al. Sleeve Gastrectomy Plus Side-to-Side Jejunoileal Anastomosis for the Treatment of Morbid Obesity and Metabolic Diseases: a Promising Operation. OBES SURG 22, 1104–1109 (2012). https://doi.org/10.1007/s11695-012-0637-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-012-0637-9

Keywords

Navigation